tiprankstipranks
Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
India Market
Want to see IN:NEULANDLAB full AI Analyst Report?

Neuland Laboratories Ltd. (NEULANDLAB) Financial Statements

5 Followers

Neuland Laboratories Ltd. Financial Overview

Neuland Laboratories Ltd.'s market cap is currently ₹213.32B. The company's EPS TTM is ₹187.17; its P/E ratio is 42.39; and it has a dividend yield of 0.08%. Neuland Laboratories Ltd. is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ₹60.52. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 20.23B₹ 14.34B₹ 15.16B₹ 11.61B₹ 9.23B
Gross Profit₹ 6.43B₹ 6.84B₹ 7.82B₹ 5.47B₹ 3.70B
Operating Income₹ 4.83B₹ 2.67B₹ 4.07B₹ 2.34B₹ 960.90M
EBITDA₹ 5.74B₹ 4.18B₹ 4.72B₹ 2.79B₹ 1.41B
Net Income₹ 3.64B₹ 2.60B₹ 3.00B₹ 1.64B₹ 638.22M
Balance Sheet
Cash & Short-Term Investments₹ 3.55B₹ 3.67B₹ 1.03B₹ 454.16M₹ 84.68M
Total Assets₹ 29.30B₹ 21.80B₹ 18.33B₹ 15.80B₹ 13.83B
Total Debt₹ 3.01B₹ 1.57B₹ 953.90M₹ 1.28B₹ 2.41B
Net Debt₹ -536.93M₹ 252.07M₹ 78.14M₹ 830.34M₹ 2.35B
Total Liabilities₹ 10.56B₹ 6.55B₹ 5.50B₹ 5.86B₹ 5.43B
Stockholders' Equity₹ 18.74B₹ 15.25B₹ 12.83B₹ 9.94B₹ 8.41B
Cash Flow
Free Cash Flow₹ -588.87M₹ 1.11B₹ 1.18B₹ 1.71B₹ -372.97M
Operating Cash Flow₹ 3.38B₹ 3.17B₹ 2.61B₹ 2.37B₹ 603.89M
Investing Cash Flow₹ -4.32B₹ -2.98B₹ -1.50B₹ -614.99M₹ -955.16M
Financing Cash Flow₹ 380.18M₹ 249.61M₹ -692.82M₹ -1.36B₹ 377.21M
Currency in INR

Neuland Laboratories Ltd. Earnings and Revenue History

Neuland Laboratories Ltd. Debt to Assets

Neuland Laboratories Ltd. Cash Flow

Neuland Laboratories Ltd. Forecast EPS vs Actual EPS